Kinsale Capital Group Inc. Boosts Stake in Humana Inc. (NYSE:HUM)

Kinsale Capital Group Inc. increased its position in Humana Inc. (NYSE:HUM - Free Report) by 21.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 11,777 shares of the insurance provider's stock after buying an additional 2,062 shares during the period. Kinsale Capital Group Inc.'s holdings in Humana were worth $3,730,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Swedbank AB raised its position in shares of Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock valued at $33,567,000 after buying an additional 3,085 shares in the last quarter. Heritage Oak Wealth Advisors LLC purchased a new stake in Humana in the 2nd quarter worth about $3,456,000. Mandatum Life Insurance Co Ltd raised its position in Humana by 115.4% in the 3rd quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider's stock worth $4,434,000 after purchasing an additional 7,500 shares during the period. APG Asset Management US Inc. raised its position in Humana by 3.0% in the 2nd quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider's stock worth $25,274,000 after purchasing an additional 1,955 shares during the period. Finally, Cetera Advisors LLC raised its position in Humana by 472.1% in the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider's stock worth $3,501,000 after purchasing an additional 8,333 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HUM shares. Stephens reissued an "equal weight" rating and issued a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Sanford C. Bernstein raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Humana from $349.00 to $250.00 and set a "hold" rating on the stock in a research report on Thursday, October 3rd. Truist Financial dropped their target price on shares of Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a research note on Friday, October 11th. Finally, Bank of America upgraded shares of Humana from an "underperform" rating to a "neutral" rating and upped their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus price target of $315.86.

Humana Stock Down 2.6 %

NYSE:HUM traded down $7.47 during midday trading on Friday, reaching $275.67. 1,842,901 shares of the stock traded hands, compared to its average volume of 2,301,719. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18. The business has a 50-day moving average of $281.36 and a two-hundred day moving average of $331.81. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $33.19 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. On average, equities analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana's dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.